June 26th 2025
AI as an accelerator for data-centric, process-centric, and human-centric clinical research.
June 16th 2025
Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.
June 9th 2025
As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and sites on transparency, sustainability, and efficiency.
May 29th 2025
A blend of FSO and FSP models in the landscape of artificial intelligence can ensure CROs stay up to date with the unique demands of industry.
May 28th 2025
While randomization is required by regulatory bodies, it is up to the sponsor on how to conduct it.
Demystifying Asian Trials
Conducting clinical research in the East brings a new group of challenges to sponsors
Imaging CROs in Asia
Improvements in image acquisition and read quality: A look at the value of standardization in oncology trials.
Darwin at Work: Trial Technology
Better access to information vastly improves the decision-making process.
Beware of Costly Consequences
Noncompliance with the US Foreign Corrupt Practices Act carries heavy penalties.
Build Trust with Honesty and Communication
The importance of openness and loyalty cannot be overlooked when cultivating a parternship.
FSP Relationships: i3 Statprobe and Eli Lilly
The partnership is an example of how CROs and sponsors interact in the ever-evolving clinical trial industry.
Cancer Trials: Raising Accrual Rates
Lessons learned from the recruitment of colorectal cander patients into clinical trials.
Strategic Partnerships Evolve
Greater product value and innovation accomplished with sponsor-service relationships.
Question and Answer with Outsourcing Leaders
Five industry veterans discuss the growth, impact, and evolution of outsourcing.
Todos Juntos por la Salud
A MMG strategic initaitve to address disparities in clinical research participation among Hispanic and Latino communities.
Understanding Non-Adherence
Inappropriate calendar pacakaging is a common occurrence leading to confusion and mistakes.
Frustration with IRB Bureaucracy & Despotism
Doing more harm than good will ultimately force human subject protection system reform.
M&A in the Pharma Industry
Organizations are seeking growth and competitive advantage through mergers and acquistions.
Chasing Veteran US Sites Out of the Enterprise
Why investigative sites are at financial risk and how it may effect sponsors and CROs.
Improve the Business of Science
Collecting too many metrics can lead to misappropriation and misinterpretation.
A Closer Look at 1572: Interpreting the FDA's Statement of Investigator Form
A new reference guide clarifies uncertainty surrounding this sometimes misunderstood document.
Key Factors in CRO Selection
A recent survey uncovers key criteria that influence a sponsor's decision when selecting a CRO.
Capturing Real World Data
There is increasing recognition of the need to understand product safety in the real world.
Timeline
A list of the most influential events affecting the clinical trials industry over the last 30 years.
Transactional vs. Strategic Sourcing
A close-up look at these two approaches to comparator drug sourcing and how they differ.
Direct-to-Patient Enrollment Strategies
A comparison of the yields and costs of online outreach methods to other recruitment techniques.
Investigator Site Survey
Results reveal insight into the roles, activities, pressures, and priorities of study coordinators.
Asia-Pac Grows With China Focus
The status of the CRO industry and doing business in the most recently emerged of the Asia-Pac regions.
Ominous Clouds Over Outsourcing
FDA and EMA may issue new guidelines on sponsor-CRO governance and responsibilities.
Triggered Monitoring
Among the many clinical development processes that need to be conducted in a smarter, more cost-effective manner, clinical data monitoring stands out as a promising area in which operational efficiencies can not only reduce costs but also improve research quality and patient safety.
Trials in Latin America
An overview of the clinical research landscape in this emerging region that also looks at its challenges.
Engaging Pharmacists in Research Education
A recent survey indicates pharmacists should provide more clinical trial information to patients.
Electronic Integration Costs
There is still an endemic inefficiency in health care and clinical trial record connectivity.
Today's Global Site Landscape
New survey from Tufts CSDD and Applied Clinical Trials provides an inside look at global sites.
Mastering Currency Fluctuation
Step-by-step process for budgeting global trials that uses a Currency Risk Management method.